Cargando…
Pcsk9 Deletion Promotes Murine Nonalcoholic Steatohepatitis and Hepatic Carcinogenesis: Role of Cholesterol
Proprotein convertase subtilisin/kexin type 9 (Pcsk9) binds to hepatic low‐density lipoprotein receptor (LDLR) and induces its internalization and degradation. Pcsk9 inhibition increases LDLR expression by hepatocytes, which causes increased uptake of circulating LDL, thereby reducing plasma LDL‐cho...
Autores principales: | Ioannou, George N., Lee, Sum P., Linsley, Peter S., Gersuk, Vivian, Yeh, Matthew M., Chen, Yen‐Ying, Peng, Yi‐Jen, Dutta, Moumita, Mascarinas, Gabby, Molla, Bruk, Cui, Julia Yue, Savard, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948564/ https://www.ncbi.nlm.nih.gov/pubmed/34816633 http://dx.doi.org/10.1002/hep4.1858 |
Ejemplares similares
-
Cholesterol Crystals in Hepatocyte Lipid Droplets Are Strongly Associated With Human Nonalcoholic Steatohepatitis
por: Ioannou, George N., et al.
Publicado: (2019) -
Understanding the physiological functions of the host xenobiotic-sensing nuclear receptors PXR and CAR on the gut microbiome using genetically modified mice
por: Little, Mallory, et al.
Publicado: (2022) -
MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis
por: de Conti, Aline, et al.
Publicado: (2017) -
Role of Cholesterol‐Associated Steatohepatitis in the Development of NASH
por: Horn, Christian L., et al.
Publicado: (2021) -
Inhibiting SCAP/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis
por: Kawamura, Satoshi, et al.
Publicado: (2022)